We had a film review yesterday with one of our better young traders. The young man can trade. But he under-performed on the Open. So we watched the video of his Open. It was like someone else was inhabiting his body. I did not recognize this type of trading from him. In fact I am not sure you can really … Read More
The Absurdity of MER
I really wanted to write this post after the market closed today. But I have been literally working on other projects for our firm for the past seven hours (11:50pm EDT now). So I’m going to share my thoughts on what I believe is a very good risk/reward trade in Merrill Lynch. MER issued a secondary about two weeks ago … Read More
Batman
Just read GMan’s blog about SMB’s Batman night. I have to add a few thoughts. 1) Watch Batman on an IMax screen. It is an incredible movie watching experience. If you live close to NYC or in NYC don’t just go see it on a regular screen. Go and find an IMax theatre. If you have already seen in on … Read More
Enjoy the Company of your Fellow Coworkers
Last Friday we had a company outing. We stopped trading a bit earlier and headed up to watch the new Batman movie in the IMAX screen. The movie was great, I mean it is hard to dislike a movie when you are watching it on a huge screen with sound so loud your seat actually shakes during explosions. After the … Read More
Summer Trading
The slow part of the summer is upon us. Seasonally this is the best time to take time off to get ready for another exciting year of trading. August is typically a very slow month in trading, especially the last two weeks of the month. If the volume and volatility is not there, it is not the time to sling … Read More
Be in the Stock When It’s Moving
As we have mentioned previously in my blog some have emailed me with concerns that program trading will rule trading soon. The market will never displace the disciplined independent trader. What is certain is that programs mandate that you adjust your trading and more selectively choose your entry points. Let’s take a look at ELN from yesterday to illustrate this … Read More
Is It Really That Bad?
Yesterday, ELN and WYE were massacred, by Wall Street standards, because of a drug that was being developed for Alzheimer’s disease and failed in phase II trials. The experimental drug was said to “only help half of patients and was linked with a brain-swelling side effect” by Bloomberg.com. (You can read more about it here: http://www.bloomberg.com/apps/news?pid=20601103&refer=news&sid=aseKG.hyyRkw) In the aftermath, ELN … Read More
You are only as good as the stocks you trade
You are only as good as the stocks you trade. Let me repeat this. You are only as good as the stocks you trade! This is a major point of emphasis on our desk. It is taught to trainees during their first week of training. And stressed on a regular basis to all traders at SMB. It is the reason … Read More
